Longer survival was seen in those with melanoma who received programmed cell death receptor-1 or its ligand who had a low neutrophil-lymphocyte ratio.
Full House alum Dave Coulier shared how his recent stage 3 Non-Hodgkin’s lymphoma diagnosis has affected his outlook on life.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback